An important role in the regulation of apoptotic calcium release is played by the ubiquitously expressed family of inositol 1,4,5-trisphosphate receptor (IP 3 R) channels. One model for IP 3 R activation during apoptosis is cleavage by the apoptotic protease caspase 3. Here we show that early elevations in cytosolic calcium during apoptosis do not require caspase 3 activity. We detected a robust increase in calcium levels in response to staurosporine treatment in primary human fibroblasts and HeLa cells in the presence of the caspase inhibitor Z-VAD, indicating that calcium release during the initiation of apoptosis occurs independently of caspase 3. Similar results were obtained with MCF-7 cells which lack caspase 3 expression. Stable expression of caspase 3 in MCF-7 cells and TAT-based transduction of the active recombinant caspase 3 directly into living MCF-7 cells had marginal effects on the early events leading to cytosolic calcium elevations and irreversible commitment to apoptotic cell death. Significantly, blocking IP 3 binding to the IP 3 R with an IP 3 sponge resulted in suppression of staurosporine-induced calcium release and cell death. Collectively, our results suggest that generation of IP 3 is sufficient for the initiation of apoptotic calcium signaling, and caspase 3-mediated truncation of IP 3 R channel is a consequence, not causative, of apoptotic calcium release.
Introduction
Calcium release into the cytoplasm is a critical regulator of almost all cellular processes including activation of cell death signaling pathways. Calcium functions as a second messenger during both early and late stages of apoptosis, orchestrating almost all facets of the apoptotic cascade. In particular, calcium release from the endoplasmic reticulum (ER) leads to increased permeability of the outer mitochondrial membrane resulting in dissipation of the mitochondrial transmembrane potential, generation of reactive oxygen species and release of pro-apoptotic proteins from mitochondria [1] . Inositol 1,4,5-trisphosphate receptor (IP 3 R) channels play a primary role in apoptotic calcium release from ER calcium stores in almost all cell types. Previous studies demonstrated that suppression of IP 3 R activity in different cell types Abbreviations: GFP, green fluorescent protein; IP3R, inositol 1,4,5-trisphosphate receptor; PARP, poly (ADP-ribose) polymerase; SERCA-2, sarco-endoplasmic reticulum calcium ATPase-2.
* Corresponding author at: 301 University Blvd, Galveston, TX 77555-0620, USA. inhibits apoptosis induced by variety of stimuli, including Fas, B and T cell receptor stimulation [2] [3] [4] .
A direct role for caspase 3 in regulation of IP 3 R-mediated calcium release was proposed upon finding that IP 3 R-1 has a consensus caspase 3 cleavage site which is not present on the other two isoforms, and cleavage at this site abolishes IP 3 -dependent calcium release [5] . IP 3 R-1 can be specifically cleaved by caspase 3 in response to multiple apoptotic stimuli, including staurosporine, anti-IgM, and TNF-␣ [5, 6] . Supporting a direct role for caspase 3 in IP 3 R cleavage, caspase 3 null MCF-7 cells do not generate cleaved IP 3 R-1 in response to apoptotic stimuli [5] . As caspase cleavage removes the N-terminal suppressor domain and the IP 3 binding domain, it has been hypothesized that cleavage at this site may cause "leaky" channels which allow calcium diffuse from the ER to the cytosol [6] [7] [8] [9] [10] . Consistent with this hypothesis, expression the IP 3 R channel domain without the ligand binding and suppressor domains results in constitutively open channels [11] . Cleavage of the receptor renders the channel insensitive to IP 3 , and recombinant IP 3 R-1 with the DEVD sequence changed to IEVA does not support caspase activation and cell death in triple IP 3 R knockout DT40 cells [5, 6] . Other reports suggest that the IP 3 R-3 specifically supports apoptotic calcium release [2, 3, 12, 13] . Furthermore, caspase 3 activation and cleavage of intracellular substrates is a relatively late event in apoptosis, and we have shown that caspase activities cannot explain the initial changes in intracellular calcium in response to apoptotic stimuli such as staurosporine and Fas ligand [14, 15] . Another group has recently confirmed that cleavage of IP 3 R-1 by caspase occurs late in apoptosis and, therefore, it is not a key event in apoptotic signaling [16] .
In the present study we addressed the functional significance of caspase 3-mediated IP 3 R-1 cleavage in the initiation of staurosporine-induced apoptotic signaling. We found that pharmacological inhibition of caspase activity in primary human fibroblasts and HeLa cells has no effect on the robust staurosporine-induced calcium release into the cytoplasm. Similarly, caspase 3 deficiency in MCF-7 cells is not associated with defects in activation of pro-apoptotic calcium signaling induced by staurosporine. Furthermore, direct introduction of active recombinant caspase 3 into untreated cells does not result in calcium leak into the cytosol. On the other hand, blocking IP 3 binding to the IP 3 R with the IP 3 sponge [17] completely abrogates calcium release from ER stores in response to staurosporine treatment, suggesting that IP 3 -mediated channel opening is the primary mechanism for calcium release during apoptosis. Taken together, our findings strongly support a caspase 3-independent model for IP 3 R-mediated calcium release during both initiation and early progression of apoptotic cell death.
Materials and methods

Cell lines
Dermal human fibroblast, MCF-7 and HeLa cell lines were obtained from ATCC. Fibroblasts were cultured in minimum essential media (Gibco) supplemented with 15% fetal bovine serum (FBS), 1× MEM non-essential amino acid solution (Sigma), 1 mM sodium pyruvate, and 1% penicillin-streptomycin. MCF-7 cells were cultured in minimum essential media (Gibco) supplemented with 10% fetal bovine serum (FBS), 1× MEM non-essential amino acid solution (Sigma), 1 mM sodium pyruvate, 10 g/ml insulin and 1% penicillin-streptomycin. HeLa cells were cultured in Dulbecco's Eagle's modified medium (Gibco) supplemented with 10% fetal bovine serum (FBS), 2 mM l-glutamine and 1% penicillin-streptomycin.
Antibodies
An antibody generated against the unique C-terminal sequence RIGLLGHPPHMNVNPQQPA (single amino acid code) of the type 1 IP 3 R has been described previously [14, 18] . Mouse monoclonal anti-␣-fodrin clone AA6 and anti-PARP1 clone C-2-10 were from Millipore. Mouse monoclonal Anti-SERCA-2 clone 2A7-A1 was purchased from Thermo Scientific.
Stable and transient transfections
For stable and transient transfections, cells were transfected using Lipofectamine 2000 as indicated by the manufacturer (Invitrogen). For generation of caspase-3 stable transfectants, MCF-7 cells were selected with 800 g/ml G418 in the culture medium 24 h after transfection with a pcDNA 3.1-based expression vector. For transient transfections, HeLa cells were plated in 6-well dishes and assessed for transfection efficiency 24 h later by visualization of green fluorescent protein.
Caspase-3 expression and purification
Expression vector containing full length caspase-3 cDNA fused to His tag was obtained from Addgene. Recombinant caspase-3 protein was purified using TALON (Clontech) resin as described [19] . Purify of the protein was analyzed by SDS-PAGE followed by Coomassie staining (Supplementary Fig. 1 ). Enzymatic activity of the fractions was determined as described below and shown in Supplementary Fig. 1B ). Fractions 1-3 were pooled, aliquoted, and frozen in 10% glycerol until use.
Green fluorescent protein (GFP) expression and purification
BL21 (DE3) E. coli cells transformed with plasmid pGFP uv , encoding the so-called Cycle 3 mutant version of GFP [20] under control the phage T7 promoter were grown to A 600 = 0.8 in LB medium and induced with 1 mM IPTG for 2 h at 37 • C. Cells were harvested by centrifugation and lysed in phosphate-buffered saline (PBS: 137 mM NaCl, 2.7 mM KCl, 10 mM Na 2 HPO 4 , 1.8 mM KH 2 PO 4 ; pH 7.4) containing EDTA-free protease inhibitor cocktail (Roche) by passing them three times through an EmulsiFlex high-pressure homogenizer device (Avestin). The lysate was cleared by centrifugation (20,000 × g for 30 min) and the supernatant was applied to a HiTrap metal-chelating column pre-charged with Ni 2+ (GE). The column was washed with a gradient of 10-50 mM imidazole in PBS, followed by desalting into PBS with a HiPrep desalting column (GE). Protein aliquots were flash-frozen in liquid nitrogen and stored at −80 • C.
Caspase-3 activity and cell death determination
Cell death was determined by propidium iodide staining as described [21] . Fluorometric determination of DEVDase (caspase-3-like) activity was performed on lysates as described [21] . 
Protein delivery
For protein transduction, the Chariot transfection reagent (Active Motif) was used according to manufacturer's instructions. Transduction efficiency was determined by separately transducing purified recombinant green fluorescent protein (GFP). Typically 100 percent of cells had intracellular GFP within 30 min (Supplementary Fig. 2 ). Calcium imaging, caspase-3 and Western blot assays were performed 3 h after Chariot/protein complex applications.
Calcium imaging
Measurements of intracellular calcium concentration were performed on Fura-2 loaded cells 14-18 h after plating on glass coverslips as described previously [22] . For long term imaging in Fig. 1E , multiple coverslips were treated simultaneously and were sequentially imaged as described [14] .
Results
Inhibition of caspase activity does not affect staurosporine-induced calcium release
To assess the role of caspase activity in the initiation of agonist and staurosporine-induced calcium release we pre-incubated HeLa cells with 20 M of the suicide caspase inhibitor Z-VAD-FMK to block all caspase activity. We observed unaltered calcium flux into cytoplasm in response to purinergic agonist ATP (1 M) in cells treated with either DMSO or Z-VAD-FMK (Fig. 1A) . Furthermore, inhibition of caspase activity did not alter kinetics and duration of staurosporine-induced calcium release (Fig. 1B) . We next examined whether staurosporine treatment was associated with degradation of the IP 3 R or other established substrates of caspase 3. Degradation of the IP 3 R was not evident even after 24 h staurosporine treatment (closed arrowhead, Fig. 1C) , and production of the Cterminal 95 kDa caspase 3 fragment was barely detectable (open arrowhead, Fig. 1C ). To examine whether staurosporine treatment resulted in cleavage of well-established caspase 3 substrates, we monitored the degradation of ␣-fodrin and PARP-1. ␣-Fodrin is cleaved during apoptosis by calpain into a 150 kDa fragment, and caspase 3 into 150 and 120 kDa fragments [23] . We found that staurosporine treatment of HeLa cells resulted in rapid production of 150 and 120 kDa fragments, and production of the 120 kDa fragment was inhibited by Z-VAD-FMK (Fig. 1C) . Furthermore, the proteolysis of PARP was rapid after staurosporine treatment and significantly inhibited by Z-VAD-FMK (Fig. 1C) . The ER resident Ca 2+ ATPase SERCA-2, which is not known to be a substrate for caspase 3, was used as a loading control. Caspase 3 enzymatic activity was robustly induced by staurosporine treatment, and completely inhibited by Z-VAD-FMK (Fig. 1D) . Thus, at least in HeLa cells, caspase 3 activation has no effect on staurosporine-induced calcium release or degradation of the IP 3 R. Furthermore, activation of the calcium-dependent apoptotic protease calpain (as determined by ␣-fodrin cleavage) was a prominent and caspase 3-independent early event in staurosporine-induced apoptosis. To determine if our findings were specific to HeLa cells, we next examined the effect of inhibiting caspase 3 activity on calcium release in primary human fibroblasts. Similar to HeLa cells, no changes in calcium flux into the cytoplasm in response to ATP or staurosporine were detected after pre-treatment of fibroblasts with Z-VAD-FMK (Fig. 1E) . Thus, caspase 3-mediated cleavage of IP 3 R channel is an unlikely mechanism to regulate staurosporine-dependent early elevations in cytosolic calcium in HeLa cells and primary human fibroblasts.
Caspase 3 does not support staurosporine-induced calcium release in MCF-7 cells
To further elucidate the role of caspase 3 in apoptotic calcium release we took advantage of the human MCF-7 breast carcinoma cell line which does not express caspase 3 as a result of a mutation within exon 3 of the CASP3 gene [24] . Caspase 3 expression was reconstituted by stable transfection of MCF-7 cells with fulllength procaspase 3. Staurosporine challenge of MCF-7 cells stably expressing caspase 3 (MCF-7/Casp3) resulted in robust induction of caspase 3 activity peaking at ∼6 h after treatment, whereas activity in wild type MCF-7 cells was undetectable ( Fig. 2A) . Next, we examined whether activation of caspase 3 would result in increased sensitivity of MCF-7 cells towards induction of apoptosis. Both MCF-7 and MCF-7/Casp3 cell lines demonstrated highly similar cell death kinetics in response to 1 M staurosporine treatment at 6, 12 and 24 h, indicating that execution of staurosporine-induced cell death is not dependent on caspase 3 (Fig. 2B ). This observation is further supported by similar patterns of ␣-fodrin cleavage in both MCF-7 and MCF-7/Casp3 cells (Fig. 2C) . Both of these results are consistent with a previous study demonstrating that deficiency of caspase 3 activity in MCF-7 cells can be partially substituted by caspase-7 during apoptosis [25] . Examination of IP 3 R-1 expression levels revealed that caspase 3 expression results in partial degradation of IP 3 R protein after 24 h of staurosporine treatment (closed arrow head, Fig. 2C ). However, this was not associated with production of the 95 kDa C-terminal caspase 3 fragment (open arrow head, Fig. 2C) , and was also associated with reduced levels of ␣-fodrin and SERCA-2 suggesting breakdown of total cellular protein.
The delayed proteolysis of the IP 3 R might also be explained by low substrate preference of caspase 3 towards IP 3 R-1. To explore this hypothesis, we treated cerebellum microsomes enriched in IP 3 R-1 protein with recombinant caspase 3. As shown in Fig. 2D , treatment of microsomes with active recombinant caspase 3 resulted in significantly faster kinetics of ␣-fodrin cleavage as compared to IP 3 R-1. Furthermore, production of the 95 kDa C-terminal fragment was not evident in these experiments (open arrowhead, Fig. 2D ), which is consistent with a recently published report [16] . The slow kinetics of IP 3 R-1 degradation in vitro and in intact cells would make it unlikely that caspase 3-mediated truncation of IP 3 R-1 contributes to the rapid mobilization of intracellular calcium seen with staurosporine treatment [14] . To address this possibility directly, we compared changes in intracellular calcium levels upon staurosporine stimulation in wild type MCF-7 and MCF-7/Casp3 cells. There were no differences in the calcium release kinetics between these two cell types up to three hours after staurosporine treatment (Fig. 2E). 
Direct introduction of active caspase 3 into MCF-7 cells does not affect calcium levels
We transduced MCF-7 cells with the recombinant caspase 3 protein to determine whether active caspase 3, in absence of other IP 3 R regulators, would result in permeabilization of the channel and subsequent calcium release from ER stores. Three hours after introduction of active caspase 3, MCF7 cells had no changes in cytosolic calcium when compared to control cells or cells transduced with caspase 3 pre-incubated with Z-VAD-FMK (Fig. 3A) . To confirm that active caspase 3 was delivered into the cells, we examined ␣-fodrin cleavage and caspase 3 enzymatic activity. A significant increase in ␣-fodrin cleavage and caspase 3 activity was detected 3 h after transduction with active caspase 3, but not in cells transduced with inactivated caspase 3 ( Fig. 3B and C) .
Staurosporine-induced calcium release depends on IP 3 generation
These results prompted us to investigate an alternative model of IP 3 R channel activation during initiation of apoptotic signaling. We hypothesized that apoptotic calcium release absolutely depends upon IP 3 generation, as has been shown for death receptor signaling [21, 26] . To examine this possibility, we measured IP 3 levels in intact HeLa cells upon staurosporine treatment using the IP 3 biosensor PLC␦1PH-GFP [27] . As shown in Fig. 4A , staurosporine treatment resulted in dissipation of PLC␦1PH-GFP fluorescence from the plasma membrane and increased cytosolic fluorescence indicative of IP 3 production. Concomitant measurement of cytosolic calcium revealed a strong correlation between the production of IP 3 and calcium release, suggesting that IP 3 generation is associated with staurosporine treatment (Fig. 4B) . To evaluate more directly the contribution of IP 3 to staurosporine-induced calcium release, we overexpressed in HeLa cells the ligand binding domain of the IP 3 R-1 protein fused to YFP (IP 3 sponge), which is known to suppress IP 3 -evoked calcium release [17] . As a control, we also overexpressed the IP 3 sponge with a point mutation eliminating IP 3 binding (K508A sponge). We transiently transfected each sponge construct into HeLa cells and monitored calcium release sequentially in response to a purinergic agonist (1 M NaATP) and 2 M staurosporine. Sponge expressing cells were identified by simultaneously imaging YFP. We found that expressing the WT sponge suppressed calcium release in response to ATP resulting in severely reduced peak amplitude of calcium release following agonist stimulation ( Fig. 4C  and D) , confirming the ability of this fusion protein to suppress IP 3 -evoked calcium release. Furthermore, WT sponge expression significantly inhibited calcium release in response to staurosporine treatment ( Fig. 4C and E) . Consistent with the requirement of IP 3 production for staurosporine-induced cell death, expression of the WT sponge significantly inhibited cell death after staurosporine treatment (Fig. 4F) . In contrast, expression of K508A sponge had no effects on calcium release kinetics or amplitude in response to ATP or staurosporine stimulation (Fig. 4G-I ). These results suggest that IP 3 gating of the IP 3 R, not caspase 3 cleavage, mediates apoptotic calcium release induced by staurosporine.
Conclusions
We have found little evidence in this model system or others [14, 21, 26] to support the notion that caspase 3 contributes significantly to IP 3 R-dependent calcium release at physiologically relevant time scales during apoptosis. In particular, IP 3 R-1 is a very weak substrate for caspase 3, and we find no evidence that caspase 3 affects the permeability of the IP 3 R in intact cells. Thus, our results argue against a physiological role of caspase 3 in calcium homeostasis. Instead, our observations strongly indicate that the initiation of apoptotic calcium release relies entirely on IP 3 generated by one of phospholipase C isoforms in response to cytotoxic stimuli.
Only the type 1 IP 3 R contains a consensus sequence for caspase 3 cleavage. Our group and others have shown that IP 3 R isoforms type 1, 2, and 3 can form hetero-oligomers [28] [29] [30] . Indeed, most cell types express varying amounts of all three IP 3 R isoforms [31] with the exception of the certain neuronal subpopulations which express primarily IP 3 R-1. A question arises whether heterotetrameric channels containing the type 1 IP 3 R as a subunit would be susceptible to caspase 3 cleavage and subsequent "leak" of calcium from the ER to the cytosol. This question may be answered by expression of various amounts of recombinant IP 3 R channel isoforms into triple IP 3 R knockout DT40 cells. This system has been instrumental investigating various aspects of IP 3 R function during apoptosis, including addressing whether caspase 3 cleavage of the channel is important. Interesting, using this system it was found that various IP 3 R constructs including wild type, caspase truncated, and channel dead (D2550A) forms of the channel all supported staurosporine-mediated calcium release and cell death, primarily by stimulating calcium entry [32] . Somewhat inconsistent with this finding, recombinant type I IP 3 R with the DEVD sequence changed to IEVA does not support caspase activation and cell death in triple IP 3 R knockout DT40 cells [6] . Regardless, our findings suggest that the IP 3 R-1 is such a poor substrate for caspase 3 that cleavage of the channel is unlikely to contribute to early calcium release events during apoptosis. It is also possible that cleavage by other proteases could contribute "leaky" IP 3 R channels, and in particular it was recently suggested that calpain cleavage of the IP 3 R may contribute to apoptotic calcium release [33, 34] . However, in our experimental systems described here and elsewhere [14] we find little or no degradation of the IP 3 R until very late in apoptosis, and this is despite robust calpain activation as determined by ␣-fodrin cleavage in the presence of Z-VAD-FMK (Fig. 1C) .
Our results complement a study which was published while this paper was under review demonstrating that the IP 3 R-1 is not cleaved using several apoptotic paradigms, and that it is a poor substrate for caspase 3 in vitro [16] . We confirm and extend these findings in this study to show that caspase 3 does not contribute to apoptotic calcium release. Furthermore, we show that IP 3 production is necessary and sufficient for apoptotic calcium release induced by staurosporine in HeLa cells (Fig. 4) . This is consistent with the absolute requirement of PLC-␥1 activity and IP 3 production for death receptor-mediated apoptotic calcium release [21, 26] . Future studies will examine how phospholipase C isoforms may be activated during initiation of the intrinsic apoptotic caspase.
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